GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » Pretax Margin %

Transcenta Holding (HKSE:06628) Pretax Margin % : -2,932.87% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Transcenta Holding's Pre-Tax Income for the six months ended in Jun. 2024 was HK$-144.09 Mil. Transcenta Holding's Revenue for the six months ended in Jun. 2024 was HK$4.91 Mil. Therefore, Transcenta Holding's pretax margin for the quarter that ended in Jun. 2024 was -2,932.87%.

The historical rank and industry rank for Transcenta Holding's Pretax Margin % or its related term are showing as below:

HKSE:06628' s Pretax Margin % Range Over the Past 10 Years
Min: -3414.75   Med: -859.48   Max: -398.88
Current: -1603.1


HKSE:06628's Pretax Margin % is ranked worse than
78.68% of 1013 companies
in the Biotechnology industry
Industry Median: -148.6 vs HKSE:06628: -1603.10

Transcenta Holding Pretax Margin % Historical Data

The historical data trend for Transcenta Holding's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding Pretax Margin % Chart

Transcenta Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
-966.28 -398.88 -3,414.75 -399.43 -859.48

Transcenta Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -938.47 -253.07 -658.91 -1,266.87 -2,932.87

Competitive Comparison of Transcenta Holding's Pretax Margin %

For the Biotechnology subindustry, Transcenta Holding's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transcenta Holding's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transcenta Holding's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Transcenta Holding's Pretax Margin % falls into.



Transcenta Holding Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Transcenta Holding's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-506.223/58.899
=-859.48 %

Transcenta Holding's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-144.092/4.913
=-2,932.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transcenta Holding  (HKSE:06628) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Transcenta Holding Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Transcenta Holding Business Description

Traded in Other Exchanges
N/A
Address
B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123
Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.
Executives
Qian Xueming 2101 Beneficial owner
Shi Xiaohong 2501 Other
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Lav Gp Iii, L.p. 2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p. 2101 Beneficial owner
Shi Yi 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a. 2301 Trustee
Success Link International L.p. 2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited 2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si 2501 Other

Transcenta Holding Headlines

No Headlines